Skip to content

Chronic Fatigue Syndrome (ME-CFS) Reference

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic multisystem disease marked by a substantial reduction in previous function, post-exertional malaise, unrefreshing sleep, and cognitive impairment or orthostatic intolerance. Its fatigue is not ordinary tiredness and is not reliably relieved by rest. The illness can affect physical, cognitive, emotional, and social activity, with severity and usable capacity varying among people and across time.

Terminology and Classification

‘’ME/CFS’’ is the principal umbrella term used by the United States Centers for Disease Control and Prevention and National Institutes of Health. ‘’CFS/ME’’ is also used, particularly in British sources. ‘’Chronic fatigue syndrome’’ remains a recognized diagnostic name, although many patients and advocates object that it reduces a complex disease to a familiar symptom. ‘’Myalgic encephalomyelitis’’ has its own clinical and historical tradition, and not every clinician, researcher, or patient treats ME and CFS as interchangeable.

The 2015 Institute of Medicine report proposed ‘’systemic exertion intolerance disease’’ to emphasize the characteristic worsening after exertion. That name did not replace ME/CFS in ordinary United States practice. Since October 2022, the United States ICD-10-CM has used G93.32 specifically for myalgic encephalomyelitis/chronic fatigue syndrome.

ME/CFS is distinct from chronic fatigue as a symptom. Persistent fatigue can accompany anemia, sleep disorders, cancer, infection, medication effects, endocrine disease, neurological disease, psychiatric illness, chronic pain, epilepsy, and many other conditions without meeting ME/CFS criteria.

Causes and Onset

No single cause or disease mechanism has been established. Many people describe acute onset after an infection, and ME/CFS is increasingly studied among infection-associated chronic conditions. Reported triggering infections include Epstein–Barr virus, Q fever, Ross River virus, and SARS-CoV-2. Only a minority of people with those infections develop ME/CFS, and a preceding infection does not identify the mechanism in an individual case.

Onset can also be gradual over months or years. Surgery, physical trauma, or major physiological or emotional stress has preceded onset in some histories, but temporal association does not prove that one event caused the illness. No evidence supports assigning a cause solely because a person also has epilepsy, autism, POTS, or another chronic condition.

Some people with Long COVID meet ME/CFS criteria, and the conditions share symptoms and research questions. They are not synonyms: Long COVID includes a wider range of post-COVID presentations, and ME/CFS can follow other infections or have no identified infectious onset.

Symptoms and Presentation

Under the 2015 Institute of Medicine criteria used by the CDC, three features are required:

  • a substantial reduction or impairment in the ability to perform pre-illness occupational, educational, social, or personal activities that persists for more than six months and is accompanied by new, profound fatigue not substantially relieved by rest;
  • post-exertional malaise; and
  • unrefreshing sleep.

The person must also have cognitive impairment, orthostatic intolerance, or both. The required symptoms should be present at least half the time and have moderate, substantial, or severe intensity. Other clinical and research criteria use different durations or symptom combinations.

Post-Exertional Malaise

Post-exertional malaise (PEM), also called post-exertional symptom exacerbation, is the worsening of the illness after activity that was previously tolerated or may appear minor to another person. Physical movement is only one source. Cognitive work, conversation, sensory exposure, emotional effort, self-care, travel, and remaining upright can also exceed the person’s current limit.

Worsening often begins twelve to forty-eight hours after the activity and may last for days or weeks. A crash can intensify fatigue, pain, cognitive impairment, sleep disruption, orthostatic symptoms, sensory intolerance, and flu-like symptoms together. Because the effect can be delayed, a person’s apparent capacity during an activity does not show what that activity will cost later.

Sleep, Cognition, and Orthostatic Intolerance

Sleep can be prolonged, fragmented, difficult to initiate, or marked by extreme daytime sleepiness, yet still fail to restore prior function. Napping may reduce immediate depletion or help a person remain within current limits; it does not necessarily return the person to baseline.

Cognitive effects can involve processing speed, attention, working memory, word retrieval, reading, multitasking, and decision-making. Their severity can change with PEM, prolonged upright posture, sensory demand, or time pressure. Cognitive impairment is not intellectual disability and does not establish a loss of language or judgment.

Orthostatic intolerance means that symptoms worsen while sitting or standing upright and improve, although not always completely, when reclining. It may include dizziness, faintness, palpitations, weakness, nausea, headache, visual disturbance, or cognitive worsening. POTS and neurally mediated hypotension are recognized forms of orthostatic intolerance, but not everyone with ME/CFS has either diagnosis, and not everyone with POTS has ME/CFS.

Other Symptoms

Possible additional features include muscle or joint pain, new or changed headaches, tender lymph nodes, sore throat, temperature dysregulation, sweating changes, sensory intolerance, nausea, bowel or bladder symptoms, and flu-like malaise. These features vary and require ordinary medical evaluation rather than automatic attribution to ME/CFS.

Variability and Severity

Symptoms and functional limits can fluctuate within a day, between days, and across longer periods. A person may sustain one valued activity by reducing everything around it. Public performance, school attendance, or a medical appointment therefore does not establish equivalent capacity for cooking, bathing, conversation, travel, or recovery afterward.

Clinical guidance commonly describes mild, moderate, severe, and very severe illness by functional effect rather than by a fixed symptom count. A mildly affected person may retain education or employment through careful scheduling and reduced activity elsewhere. Moderate illness may prevent a regular schedule and substantially limit upright, social, and domestic activity. Severe or very severe illness may involve wheelchair dependence, long periods at home or in bed, extensive sensory intolerance, and assistance with self-care, nutrition, communication, or repositioning.

These categories are not permanent identities or exact percentages of lost function. A person can move between them, have a relapse that lowers the previous baseline, or have different physical and cognitive limits at the same time.

Diagnosis and Differential Diagnosis

No blood test, scan, exercise test, or biomarker confirms every case. Diagnosis uses a detailed history of prior and current function, the quality and timing of PEM, sleep, cognition, upright tolerance, symptom frequency and severity, physical and neurological examination, and targeted laboratory testing. Family observations can help in pediatric assessment without replacing the young person’s own account.

ME/CFS is actively diagnosed from its characteristic pattern rather than established only after every possible disease has been excluded. The workup nevertheless investigates other explanations and co-occurring conditions, including anemia, thyroid and adrenal disease, diabetes, infection, inflammatory or autoimmune illness, primary sleep disorders, medication effects, malnutrition, cardiac disease, neurological disease, cancer, major depressive disorder, and substance use.

Coexistence matters. Treating sleep apnea, depression, migraine, epilepsy, POTS, pain, or a nutritional deficiency can improve that problem without necessarily resolving ME/CFS. Conversely, a psychiatric history does not by itself explain PEM or make a physical evaluation unnecessary.

Treatment and Management

There is no cure or United States–approved disease-specific treatment. Management is individualized around the symptoms the person identifies as most disruptive, while avoiding interventions that worsen PEM.

Energy Management

Energy management, often called pacing, balances activity and rest within the person’s changing physical, cognitive, emotional, social, and sensory limits. Useful approaches can include breaking tasks into smaller parts, alternating kinds of demand, resting before symptoms become severe, working while seated or reclined, tracking delayed effects, and reserving capacity for personally important activities.

Pacing is not a promise that every crash can be prevented. Essential self-care, school, work, caregiving, medical visits, inaccessible environments, and unpredictable changes in the illness can exceed a person’s limit despite careful planning.

The 2021 NICE guideline advises against graded exercise therapy defined as fixed incremental increases based on deconditioning or exercise-avoidance theories. Standard aerobic exercise prescriptions can cause deterioration. Any movement or physical-activity plan must begin within the person’s current limits, remain flexible, and be reduced or stopped when symptoms worsen. Gentle movement may help some people preserve comfort or range of motion, but it is not a cure.

Symptom and Comorbidity Care

Treatment can address orthostatic intolerance, sleep disorders, pain, migraine, gastrointestinal symptoms, sensory intolerance, depression, anxiety, and other co-occurring conditions. Medication response and sensitivity vary, so benefits, adverse effects, interactions, and effects on upright tolerance or cognition require monitoring.

Mental-health care can treat depression, anxiety, trauma, grief, and the strain of chronic illness. Cognitive behavioral therapy may be used for coping or another co-occurring condition; it is not a cure for ME/CFS. Antidepressants can treat an indicated psychiatric condition but do not treat the core disease merely because fatigue and reduced activity are present.

Severely affected people may need home-based or remote care, a quiet and dark environment, help with nutrition and hydration, pressure-injury prevention, transfer and toileting equipment, and assistance with repositioning or very gentle range-of-motion work. Complete bed rest carries its own risks and is reserved for circumstances in which the illness makes it necessary.

Course and Prognosis

The course is heterogeneous. Some people improve substantially or partially, while others remain ill, fluctuate, relapse, or lose function over time. Children and adolescents may have better prospects for partial or full improvement than adults as a group, but population patterns cannot predict an individual outcome.

Exceeding current limits can produce a temporary flare, a prolonged relapse, or a lower functional baseline. Early recognition and appropriate management may reduce avoidable worsening, but neither timely diagnosis nor strict pacing guarantees recovery. Apparent improvement must be distinguished from a life narrowed enough to avoid repeated crashes.

Historical Context and Medical Evolution

Outbreaks resembling later descriptions of ME/CFS were recorded beginning in 1934. The term ‘’benign myalgic encephalomyelitis’’ emerged after the 1955 Royal Free Hospital outbreak in London; ‘’benign’’ referred to mortality rather than the severity or duration of disability and later fell out of favor.

During the 1980s, some United States cases were attributed to chronic Epstein–Barr virus infection. Evidence did not establish Epstein–Barr virus as a universal cause. A CDC working group introduced ‘’chronic fatigue syndrome’’ and published a research case definition in 1988. The 1994 Fukuda research definition broadened and standardized case selection but did not require PEM, contributing to continuing debate about who was included in CFS research.

The 2015 Institute of Medicine report recognized ME/CFS as a serious systemic disease, centered PEM in simplified clinical criteria, and proposed the name ‘’systemic exertion intolerance disease’‘. In 2021, NICE replaced its 2007 guidance and rejected fixed-increment graded exercise therapy and curative cognitive-behavioral framing. Long COVID later expanded research and public attention around infection-associated chronic illnesses without erasing the distinct histories of ME/CFS and Long COVID.

Associated Characters

Cody Matsuda

Main article: Cody Matsuda

Cody developed severe, persistent fatigue around age fourteen. By 1995, the illness affected school attendance, cognition, pain, activity tolerance, and social participation, but clinicians repeatedly attributed his symptoms to ordinary tiredness or depression. He remained without a formal ME/CFS diagnosis through at least 1997 even though the 1988 and 1994 research definitions made clinical recognition possible.

In spring 1995, Cody disclosed that he did not want to wake the next day. A physician dismissed the statement without an emergency psychiatric evaluation, and Cody later attempted suicide with prescribed fluoxetine. Chronic illness, repeated medical dismissal, depression, and isolation formed part of that crisis; ME/CFS did not make the attempt inevitable or replace the need to treat his psychiatric health separately.

After the attempt, the Matsuda-Davis Homeschool Cooperative let Cody study on a flexible schedule with a mandatory midday rest period, accessible communication, and the option to work lying down. He began using a manual wheelchair for longer outings circa 1996–1997 and later used a power wheelchair full-time. His public writing addressed ME/CFS, medical dismissal, communication access, and masculinity, including the essay ‘’Invisible Until Inconvenient: CFS, Masculinity, and Medical Dismissal’‘.

Charlie Rivera

Main article: Charlie Rivera

Charlie had severe fatigue and a need for daytime sleep by age twelve to thirteen. By high school, he sometimes fell asleep at the lunch table or against classroom walls and slept until noon when his schedule permitted. The sleep limited further depletion but did not restore him to baseline. School and music demands repeatedly produced PEM, and other people sometimes interpreted his visible sleep and later activity as laziness or inconsistency.

Charlie continued taking mandatory rest periods through Juilliard. His 2027 hospitalization confirmed gastroparesis and, through repeat upright testing after volume and nutritional stabilization, POTS, while ME/CFS remained undiagnosed until 2029. The diagnosis required CRATB to restructure touring, rehearsal, rest, and performance expectations. The album ‘’Crip Time’’ grew from that changed working reality, and Charlie cited Cody’s writing in his own disability advocacy.

POTS, migraine, gastroparesis, chronic vestibular dysfunction, hEDS, and later nutritional compromise interacted with Charlie’s energy and upright tolerance without becoming interchangeable with ME/CFS. A power wheelchair, reclined work, reduced touring, electronic AAC, signing, and rest before and after performances preserved access to music and public life as his capacity changed.

Mateo Garcia

Main article: Mateo Garcia

Mateo had suspected ME/CFS rather than a confirmed diagnosis. Disabling fatigue and post-exertional crashes affected school attendance, concentration, mobility, and participation. He used a power wheelchair at school and during public outings to conserve energy. Refractory epilepsy, seizure recovery, medication effects, depression, anxiety, and sleep disruption could also contribute to fatigue and required assessment alongside the suspected ME/CFS pattern.

Minjae Lee

Minjae had severe chronic fatigue as part of a complex medical presentation but did not have a separate ME/CFS diagnosis. His fatigue remained clinically and functionally important without being converted into ME/CFS solely because he also had POTS, gastroparesis, epilepsy, autism, and cerebral palsy.

Daily Life and Accessibility

ME/CFS can affect attendance, work hours, reading, conversation, self-care, food preparation, transportation, appointments, relationships, and recovery time. Access may include flexible or reduced schedules, remote participation, extended deadlines, home instruction, rest spaces, low-sensory environments, task simplification, written information, and permission to participate while reclined.

Mobility equipment can reduce upright demand, falls, pain, and energy expenditure. Wheelchair use is not proof that a person cannot walk, and walking during one period does not make later or part-time wheelchair use unnecessary. Shower chairs, bedside equipment, adjustable beds, power-assist devices, and environmental automation can make essential tasks possible within a smaller energy limit.

Communication also costs energy. Speech, signing, typing, AAC, listening, and processing conversation can each become less accessible during PEM. Multiple communication methods, additional response time, shorter interactions, low-tech backups, and communication partners who accept delayed or reduced responses can preserve autonomy.

Medical-System Interactions

Delayed diagnosis can result from the absence of a confirmatory test, inconsistent criteria, limited clinician education, and disbelief that the disease is physiological. Symptoms may be labeled depression, anxiety, school avoidance, laziness, or deconditioning without adequate investigation. People with severe disease can also be missing from clinic-based impressions because travel and the visit itself exceed their capacity.

Diagnosis rates do not necessarily show biological distribution. CDC material notes that white people are diagnosed more often while people from racial and ethnic minority groups are especially likely to remain undiagnosed. Cody, Charlie, and Mateo each encountered or risked age-, gender-, disability-, or race-linked interpretations that could obscure the medical pattern; their specific histories remained distinct rather than examples of one universal experience.

Public and Community Context

The contrast between a person’s visible activity and the delayed cost of that activity has repeatedly fueled disbelief. A musician who performs one set, a student who attends one class, or a wheelchair user who stands briefly may have sacrificed other activities or may experience PEM after observers have left.

Community advocacy has emphasized the biological reality of ME/CFS, the centrality of PEM, the harm of forced activity, and the difference between pacing and giving up. Cody’s writing and Charlie’s music and public documentation placed those issues in the context of masculinity, queerness, race, artistic labor, and communication disability without treating either man as representative of every person with ME/CFS.

Sources

Medical Conditions Chronic Conditions Neurological Conditions